Our Services
Due Diligence and Portfolio Analysis
Characterize your new asset or portfolio through the lens of value and access
Ensure your plans are aligned to meet health stakeholder and market needs for your health technology type or platform. Consider partnering options
Pressure test your forecast and ROI approaches to ensure they are optimized
Evidence Generation Planning and HEOR
Develop comprehensive evidence plans that consider clinical, regulatory, RWE and access - with a lens on transformative differentiation
Optimize your development spend by focusing on the activities that drive value for your asset - integrate a multi-stakeholder perspective that does not leave value on the table
Value and Access Strategy
Develop and pressure test a comprehensive value and access strategy aligned to the unique attributes of your emerging health technology
Incorporate unique approaches that have been leveraged to accomplish 1st in world milestones for transformative technologies
RWE and Next Generation Evidence Approaches
Leverage RWE and other next generation evidence development approaches to build a bespoke value engine that is make for your asset scenario
Characterize multiple dimension of value and stay ahead of the competition by leveraging demonstrated approaches
Health Policy Analysis & Communication
Truly novel health technologies often emerge in global regulatory, reimbursement and pricing systems that never anticipated them
Leverage our deep experience in shaping the policy landscape for multiple health technology types via publications, sentinel reports, and stakeholder partnerships
Executive Advising and Board Positions
Leverage >25 years of experience to help ensure your transformative technology business is poised for transformative growth and performance
Services range from ad hoc business advising to board positions